Related Experiment Videos
[Immunotherapy of prostate cancer]
1Urologische Klinik, Ruhr-Universität Bochum, Marienhospital Herne.
Der Urologe. Ausg. A
|September 1, 1993
Summary
Immunotherapy for prostate cancer shows promise but lacks clinical breakthroughs. Future research focuses on specific immunologic strategies for advanced prostate cancer treatment.
Area of Science:
- Urology
- Immunology
- Oncology
Context:
- Prostate cancer immunotherapy is an emerging research area.
- Despite advances in other cancers, prostate cancer immunotherapy has not yet achieved clinical success.
- Current research explores both specific and nonspecific immunotherapeutic approaches.
Purpose:
- To review the current state of prostate cancer immunotherapy.
- To discuss various immunotherapeutic strategies and their mechanisms of action.
- To identify potential future directions for effective prostate cancer treatment.
Summary:
- Investigational therapies include monoclonal antibodies, adoptive immunotherapy, tumor cell vaccination, and biological response modifiers.
- While some studies offer insights into tumor biology, significant clinical breakthroughs are still needed.
- The focus is on developing immunologically specific concepts for systemic therapy.
Impact:
- Ongoing research aims to uncover immunological mechanisms for effective prostate cancer treatment.
- Immunologically specific concepts hold the most promise for developing novel therapies.
- Future immunotherapies may offer more effective treatment options than androgen ablation for advanced prostate cancer.